Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nunzio Del Gaudio

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Clinical Epigenetics|September 9, 2024
Epitranscriptomics and epigenetics: two sides of the same coin?Guglielmo Bove, Nunzio Del Gaudio, Lucia Altucci
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2022
MicroRNA Expression Profiling Using Agilent One-Color MicroarrayCarmela Dell'Aversana, Giulia Sgueglia, Nunzio Del Gaudio, et al.
Cancers|July 18, 2020
The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic OptionsAntonella Di Costanzo, Nunzio Del Gaudio, Lidio Conte, et al.
Archives of Toxicology|August 3, 2014
Epigenetic drugs against cancer: an evolving landscapeAntonella Di Costanzo, Nunzio Del Gaudio, Antimo Migliaccio, et al.
Frontiers in Oncology|November 15, 2021
KDM4 Involvement in Breast Cancer and Possible Therapeutic ApproachesBenluvankar Varghese, Nunzio Del Gaudio, Gilda Cobellis, et al.
Medicine|June 21, 2018
Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation: A case reportGerardo Rosati, Nunzio Del Gaudio, Enrico Scarano, et al.
International Journal of Cancer|November 29, 2022
Interplay between m<sup>6</sup> A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectivesGuglielmo Bove, Sajid Amin, Mehrad Babaei, et al.
Genome Research|September 26, 2020
Genome-wide dynamics of RNA synthesis, processing, and degradation without RNA metabolic labelingMattia Furlan, Eugenia Galeota, Nunzio Del Gaudio, et al.
International Journal of Cancer|June 27, 2024
The m<sup>6</sup>A-independent role of epitranscriptomic factors in cancerGuglielmo Bove, Marco Crepaldi, Sajid Amin, et al.
Cancers|September 14, 2024
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung CancerMuhammad Aamir Wahab, Nunzio Del Gaudio, Biagio Gargiulo, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Clinical Epigenetics|September 9, 2024
Epitranscriptomics and epigenetics: two sides of the same coin?Guglielmo Bove, Nunzio Del Gaudio, Lucia Altucci
Methods in Molecular Biology (Clifton, N.J.)|November 28, 2022
MicroRNA Expression Profiling Using Agilent One-Color MicroarrayCarmela Dell'Aversana, Giulia Sgueglia, Nunzio Del Gaudio, et al.
Cancers|July 18, 2020
The Ubiquitin Proteasome System in Hematological Malignancies: New Insight into Its Functional Role and Therapeutic OptionsAntonella Di Costanzo, Nunzio Del Gaudio, Lidio Conte, et al.
Archives of Toxicology|August 3, 2014
Epigenetic drugs against cancer: an evolving landscapeAntonella Di Costanzo, Nunzio Del Gaudio, Antimo Migliaccio, et al.
Frontiers in Oncology|November 15, 2021
KDM4 Involvement in Breast Cancer and Possible Therapeutic ApproachesBenluvankar Varghese, Nunzio Del Gaudio, Gilda Cobellis, et al.
Medicine|June 21, 2018
Unexpected and durable response with regorafenib in a metastatic colorectal cancer patient without KDR mutation: A case reportGerardo Rosati, Nunzio Del Gaudio, Enrico Scarano, et al.
International Journal of Cancer|November 29, 2022
Interplay between m<sup>6</sup> A epitranscriptome and epigenome in cancer: current knowledge and therapeutic perspectivesGuglielmo Bove, Sajid Amin, Mehrad Babaei, et al.
Genome Research|September 26, 2020
Genome-wide dynamics of RNA synthesis, processing, and degradation without RNA metabolic labelingMattia Furlan, Eugenia Galeota, Nunzio Del Gaudio, et al.
International Journal of Cancer|June 27, 2024
The m<sup>6</sup>A-independent role of epitranscriptomic factors in cancerGuglielmo Bove, Marco Crepaldi, Sajid Amin, et al.
Cancers|September 14, 2024
Exploring the Role of CBX3 as a Potential Therapeutic Target in Lung CancerMuhammad Aamir Wahab, Nunzio Del Gaudio, Biagio Gargiulo, et al.
Pageof 4